Page 5 of 18 · 416 questions tagged gi-side-effects.
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
I am asking about the protocol logic rather than about my own case specifically. This is presented as though it settles something, and I am not convinced it does. I…
What I have: SUSTAIN-6 · early satiety · 50 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Details up front: SURMOUNT-OSA · hair thinning · 4 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
The particulars: reflux · ecnoglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
Concretely: early satiety · liraglutide · STEP 1. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
My records go back to the first dose with dates, so I can reconstruct the timeline exactly. I would like to know the limits of what can be inferred from this. What I…
Numbers first: dizziness · five · liraglutide. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.…
Conditions: ATTAIN-1 · dizziness. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
The case in front of me: nausea · liraglutide · SURMOUNT-1. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The case in front of me: headache · oral semaglutide · SURPASS-2. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The case in front of me: SELECT · injection-site erythema. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
Concretely: REDEFINE-1 · vomiting · 5 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The label documentation for the agent in question is ambiguous on exactly this point. The figures are clear enough; the question is what they mean and what they do…
The case in front of me: nausea · tirzepatide · SURMOUNT-2. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
This came up because two published schedules for the same agent differ. I would like help reading this properly rather than being told what conclusion to reach. I…
Details up front: dizziness · orforglipron · SURPASS-3. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
Setup, so nobody has to ask: PIONEER-1 · fatigue · 10 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Setup, so nobody has to ask: FLOW · vomiting. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The label documentation for the agent in question is ambiguous on exactly this point. I have read the primary source rather than the summary, which has left me with…
Setup, so nobody has to ask: constipation · mazdutide · SURMOUNT-2. I have read the primary source rather than the summary, which has left me with more questions. I…
What I have: injection-site erythema · five · oral semaglutide. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Two related mechanism questions I have never seen answered together. First, how much of the weight loss is attributable to delayed gastric emptying as opposed to…
Details up front: vomiting · orforglipron · SURMOUNT-1. This is presented as though it settles something, and I am not convinced it does. I have two documents that…